ArticleJournal of experimental & clinical cancer research : CR2019

Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.

Zhan-Hong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.